PGNY

Progyny, Inc.

• NASDAQ·2d ago

  Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock

• Dow Jones·08/26 15:53

  Progyny Is Maintained at Neutral by JP Morgan

• Dow Jones·08/26 15:53

  Progyny Price Target Raised to $25.00/Share From $23.00 by JP Morgan

• TipRanks·08/26 12:55

  Progyny price target raised to $25 from $23 at JPMorgan

• NASDAQ·08/22 10:44

  Analysts Anticipate SLYG To Hit $108

• Dow Jones·08/20 14:09

  Progyny Price Target Raised to $23.00/Share From $21.00 by Canaccord Genuity

• Dow Jones·08/20 14:09

  Progyny Is Maintained at Hold by Canaccord Genuity

• TipRanks·08/20 10:55

  Progyny’s Cautious Optimism Amid Challenges: A Hold Rating Analysis

• TipRanks·08/20 10:30

  Progyny price target raised to $23 from $21 at Canaccord

• TipRanks·08/14 02:03

  Director Cashes In on Progyny Stock Sale!

• TipRanks·08/13 00:29

  Progyny’s Earnings Call Highlights Robust Growth and Strategic Partnerships

• TipRanks·08/12 10:30

  Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Progyny (PGNY) and Avadel Pharmaceuticals (AVDL)

• TipRanks·08/08 17:35

  Cantor Fitzgerald Sticks to Its Buy Rating for Progyny (PGNY)

• Dow Jones·08/08 15:30

  Progyny Price Target Raised to $28.00/Share From $26.00 by Cantor Fitzgerald

• Dow Jones·08/08 15:30

  Progyny Is Maintained at Overweight by Cantor Fitzgerald